Massimo Di Maio, M.D.
National Cancer Institute, Naples
5
5
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Francesco Perrone, M.D., Ph.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Worked with same sponsors:
Ciro Gallo, M.D., Ph.D
Second University of Naples, Italy; Chair of Medical Statistics
Shared therapeutic areas:
Worked with same sponsors:
Secondo Lastoria, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Cesare Gridelli, M.D.
S.G. Moscati Hopital, Avellino, Italy, Division of Medical Oncology
Shared therapeutic areas:
Worked with same sponsors:
Alessandro Morabito, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Gaetano Rocco, M.D.
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
Ciro Gallo, M.D., Ph.D.
University of Campania Luigi Vanvitelli
Shared therapeutic areas:
Worked with same sponsors:
Marilina Piccirillo, MD
National Cancer Institute, Naples
Shared therapeutic areas:
Worked with same sponsors:
A. Pession
Policlinico S. Orsola-Malpighi, Bologna
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in Children
PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy
All 5 trials loaded